Adriana Bonansea Frances, MD
Allergy & Immunology · Homestead, FLNPI 1356522155
Payments from drug & device makers
Across 537 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$5K
- Regeneron Healthcare Solutions, Inc.$2K
- AstraZeneca$2K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- CSL Behring$2K
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 62 | $4,777 |
| Regeneron Healthcare Solutions, Inc. | 55 | $2,074 |
| AstraZeneca | 66 | $1,922 |
| GSK | 66 | $1,685 |
| Takeda Pharmaceuticals U.S.A., Inc. | 61 | $1,624 |
| CSL Behring | 56 | $1,561 |
| Pharming Healthcare, Inc. | 16 | $700 |
| Genentech USA, Inc. | 15 | $579 |
| Biocryst US Sales Co., LLC | 32 | $549 |
| Grifols USA, LLC | 21 | $411 |
| Novartis | 15 | $365 |
| Amgen(2 entities) | 12 | $294 |
| Teva Pharmaceuticals USA, Inc. | 5 | $237 |
| Lilly USA, LLC | 4 | $204 |
| Shire North American Group Inc | 8 | $193 |
| Optinose US, Inc. | 7 | $159 |
| Pfizer | 7 | $146 |
| Genentech, Inc. | 1 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $98 |
| Octapharma USA, Inc. | 4 | $93 |
| Hikma Pharmaceuticals USA | 4 | $65 |
| Ionis Pharmaceuticals, Inc. | 2 | $63 |
| Biocryst Pharmaceuticals, Inc. | 2 | $54 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| AbbVie | 2 | $45 |
| Merck | 2 | $39 |
| Boehringer Ingelheim | 2 | $39 |
| Alk-abello, Inc | 2 | $34 |
| Galderma Laboratories, L.p. | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $20 |
| USWM, LLC | 1 | $17 |
How this compares
$18,313 in reported general payments places this provider in the 75th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Homestead
- Jaime LandmanAventura$3.9M
- Ileana RodicioMiami$3.8M
- Jose CarpioMiami$3.6M
- Michael KohenDaytona Beach$3.6M
- Thomas CasaleTampa$1.7M
- Dennis LedfordTampa$1.4M
- Ronald SaffTallahassee$1.2M
- Shahnaz FattehPlantation$1M
- Seong ChoTampa$969K
- Thomas WestbrookPensacola$925K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.